ARID1A mutations confer intrinsic and acquired resistance to cetuximab treatment in colorectal cancer.
Nat Commun. 2022 Sep 19;13(1):5478. doi: 10.1038/s41467-022-33172-5.
Nat Commun. 2022.
PMID: 36117191
Free PMC article.